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Abstract
Background The measurement of handgrip strength (HGS) has prognostic value with respect to all-cause mortality, cardiovascular
mortality and cardiovascular disease, and is an important part of the evaluation of frailty. Published reference ranges for HGS are
mostly derived from Caucasian populations in high-income countries. There is a paucity of information on normative HGS values
in non-Caucasian populations from low- ormiddle-income countries. The objective of this study was to develop reference HGS ranges
for healthy adults from a broad range of ethnicities and socioeconomically diverse geographic regions.
Methods HGS was measured using a Jamar dynamometer in 125,462 healthy adults aged 35-70 years from 21 countries in
the Prospective Urban Rural Epidemiology (PURE) study.
Results HGS values differed among individuals from different geographic regions. HGS values were highest among those
from Europe/North America, lowest among those from South Asia, South East Asia and Africa, and intermediate among those
from China, South America, and the Middle East. Reference ranges stratiﬁed by geographic region, age, and sex are presented.
These ranges varied from a median (25th–75th percentile) 50 kg (43–56 kg) in men <40 years from Europe/North America to
18 kg (14–20 kg) in women >60 years from South East Asia. Reference ranges by ethnicity and body-mass index are also
reported.
Conclusions Individual HGS measurements should be interpreted using region/ethnic-speciﬁc reference ranges.
Keywords handgrip strength; muscle strength; reference range; normative range; reference value
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Introduction
There is convincing evidence to indicate that handgrip strength
(HGS) is of prognostic importance in the general population1–6
and in those with existing disease.7 HGS has prognostic value
with respect to all-cause mortality,3,5,6,8,9 cardiovascular
mortality,5,10 and cardiovascular disease (CVD).5 independently
of recognised confounding factors, including dietary habits,
physical activity, and socioeconomic status. Weak HGS is also
associated with high case-fatality rates in individuals who
develop any of a range of major illnesses,5 suggesting that
low muscle strength may be an important indicator of vulnera-
bility to disease and of frailty. Moreover, HGS is rapid and
simple to measure, and is inexpensive. It is therefore appealing
as a tool to stratify an individual’s risk of developing CVD, or of
susceptibility to death from an incident illness. HGS correlates
closely with measures of muscle strength from other muscle
groups, including the lower limbs.11,12 Its prognostic value,
the simplicity of measurement with minimal training, portabil-
ity, and low cost make it an attractive clinical test to evaluate an
individual’s overall health in clinical or epidemiologic settings.
HGS evaluation is a core part of the clinical evaluation of
frailty.13 HGS measurement is not, however, in widespread
use as a risk-stratifying tool.
The lack of globally applicable reference ranges for HGS may
account at least in part for its failure to be adopted clinically.
Reference ranges for HGS have been reported in a number of
studies, however the large majority of these studies have been
undertaken in convenience samples of individuals of predomi-
nantly European ethnicity and in high-income countries.14–21
There is a paucity of normative, population-derived data on
HGS, particularly from non-Caucasian populations in low- to
middle-income countries.8,22,23 Given that HGS represents the
product of age, general health, and comorbid conditions, an
understanding of what constitutes “normal” HGS in different
ethnic groups and geographic regions is important. Therefore,
the objective of this study was to develop reference HGS ranges
for healthy adults from a broad range of ethnicities and socioeco-
nomically diverse geographic regions.
The Prospective Urban Rural Epidemiology (PURE) study is a
prospective cohort study of in excess of 160,000 community-
based adults from 21 low-, middle- and high-income countries.24
The present study is an analysis of the 125,462 healthy PURE
participants from these 21 countries who had HGS measured.
Methods
Study design and participants
The design of the PURE study have been described previously.24
In brief, participating countries were selected to represent
signiﬁcant socioeconomic heterogeneity. For reasons of feasi-
bility, proportionate sampling of all countries worldwide, or of
Table 1. Participant characteristics stratiﬁed by geographic region. Displayed are median (25th–75th percentile) values, mean ± standard deviation
values, or column percentages
Characteristic
Europe/North America South America Middle East Africa
Women Men Women Men Women Men Women
N 9362 7221 12,163 7704 4241 3901 3022
Age, years 51
(44–58)
52
(44–59)
50
(43–58)
50
(43–59)
45
(39–52)
46
(40–53)
49
(41–57)
Rural location 29 30 41 49 43 39 53
Education
Primary 22 18 58 61 59 35 71
Secondary 28 28 26 22 30 38 28
Post-secondary 50 54 16 17 11 27 1
Employed 68 74 60 70 46 83 10
Physical activity
Low 8 10 10 15 24 28 16
Medium 39 34 35 29 54 36 38
High 53 56 55 56 22 36 46
Tobacco use
Former 27 35 16 30 <1 12 2
Current 14 23 19 25 <1 30 22
Never 59 42 65 45 99 58 76
Alcohol use
Former 5 7 6 12 0 2 3
Current 60 72 33 62 0 1 19
Never 35 21 61 26 100 97 78
Daily caloric intake, kcal 1941
(1513–2481)
2379
(1852–3004)
2026
(1561–2562)
2216
(1723–2824)
2099
(1622–2677)
2332
(1879–2887)
1848
(1337–2646)
Percentage of caloric
intake from protein
16.5 ± 2.8 16.3 ± 2.7 16.9 ± 3.5 16.4 ± 3.4 17.1 ± 2.4 17.2 ± 2.2 13.6 ± 3.0
Height, cm 161± 7.2 175± 7.8 156± 7.0 169± 7.6 156± 6.2 170± 6.9 157± 6.6
Weight, kg 72± 15 85± 15 69± 15 78± 17 71± 15 78± 15 70± 20
Waist circumference, cm 85± 13 95± 12 89± 13 94± 12 89± 13 91± 12 85± 15
Body-mass index, kg/m2 27.7 ± 6.04 27.7 ± 5.60 28.2 ± 5.85 27.5 ± 5.04 29.3 ± 5.76 27.0 ± 4.82 28.3 ± 7.69
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regions within countries, was not undertaken. Countries
selected included Canada, Saudi Arabia, Sweden, United Arab
Emirates (high-income countries), Argentina, Brazil, Chile,
China, Colombia, Iran, Malaysia, Poland, South Africa, Turkey,
Philippines (middle-income countries), Bangladesh, India,
Pakistan, Palestine, Tanzania, and Zimbabwe (low-income
countries). Within both urban and rural communities in each
country, households were selected to achieve representative
sampling within the community. peciﬁc methods used to ap-
proach households may have varied according to country con-
text. For example, in low-income settings, a community
announcement may be made through a community leader,
followed by door-to-door visits. In high-income settings, initial
approaches may have been made by telephone. Guidelines
for the selection of countries, communities, households, and
individuals to participate are presented in the Appendix, Table
5. Household members were invited to participate if aged 35-
70 years.
Procedures
Trained study personnel administered a standardised set of
questions to participants. These questions elicited self-reported
ethnicity, demographics, cardiovascular risk factors, co-morbid
conditions, education status, employment status, physical
activity levels, tobacco and alcohol use, and dietary patterns.
Study personnel also measured participant anthropometrics
(height, weight, and waist circumference). Education was
classiﬁed as up to secondary school, secondary school, and
university/trade school.
HGS was measured using a Jamar dynamometer (Sammons
Preston, Bolingbrook, IL, USA) according to a standardised
protocol.25 The arm was positioned at the side of the body
and the dynanometer held with elbow ﬂexed to 900. The par-
ticipant was asked to squeeze the device as hard as possible
for 3 seconds. The measurement was repeated twice more at
intervals of at least 30 seconds. For the ﬁrst study
participants, three measurements were made from the par-
ticipant’s non-dominant hand. During the course of the study,
the protocol was amended so that three measurements were
made from both hands of each participant. For the present
analysis, we used only the maximum values obtained from
each hand. Overall HGS was then calculated as the mean of
non-dominant and dominant hand HGS.5 To permit
estimation of overall HGS in participants where values were
missing for one hand but present for the other hand, we im-
puted values for the missing hand using the coefﬁcient and
constant from the linear regression of non-dominant and
dominant hand HGS.5 We also present reference ranges
where HGS is the maximum value obtained from both hands
(Appendix).26
The PURE study was approved by the appropriate
research ethics committees and has been performed in
Table 1. (Continued)
Characteristic
Africa South East Asia South Asia China
Men Women Men Women Men Women Men
N 1282 6002 4097 14,729 10,976 23,884 16,878
Age, years 50
(42–58)
49
(42–57)
52
(44–59)
45
(38–54)
47
(40–56)
50
(42–57)
51
(42–58)
Rural location 52 55 55 54 53 51 54
Education
Primary 69 39 37 60 44 37 27
Secondary 29 44 43 31 39 50 56
Post-secondary 2 17 20 9 17 13 17
Employed 14 42 71 50 82 53 68
Physical activity
Low 15 14 20 17 20 13 19
Medium 33 43 34 39 27 44 39
High 52 43 46 44 53 43 42
Tobacco use
Former 9 2 18 <1 8 <1 9
Current 47 3 32 9 44 3 52
Never 44 95 50 91 48 97 39
Alcohol use
Former 9 2 5 <1 5 1 6
Current 50 5 10 <1 22 5 46
Never 41 93 85 99 73 94 48
Daily caloric intake, kcal 1925
(1365–2708)
2462
(1661–3417)
2535
(1745–3674)
1869
(1468–2477)
2164
(1643–2880)
1784
(1423–2198)
2125
(1704–2621)
Percentage of caloric
intake from protein
13.2 ± 3.1 16.7 ± 3.4 16.6 ± 3.4 11.5 ± 1.9 11.5 ± 2.0 15.5 ± 2.8 14.8 ± 2.9
Height, cm 167± 7.2 152± 6.4 163± 6.9 153± 6.6 165 ± 7.2 156± 5.8 167± 6.5
Weight, kg 62± 15 62± 14 69± 15 54± 13 60± 14 60± 11 69± 12
Waist circumference, cm 79± 11 83± 12 89± 12 75± 13 79± 13 79± 10 83± 10
Body-mass index, kg/m2 22.0 ± 5.34 26.4 ± 5.42 25.8±4.77 23.2±5.33 22.1±4.44 24.6±4.07 24.4±3.83
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accordance with the ethical standards laid down in the
1964 Declaration of Helsinki and its later amendments,
and also in accordance with relevant national laws
governing human research ethics.
Statistical analysis
For the present analysis, because we sought to describe refer-
ence ranges among healthy individuals, participants were not in-
cluded if HGS was not measured in either hand, sex was not
recorded, or if the participant had a history of cancer, chronic
obstructive pulmonary disease, tuberculosis, Chagas disease,
human immunodeﬁciency virus, stroke, coronary artery disease,
heart failure, or diabetes. Countries were grouped to permit
adequate participant numbers for stratiﬁed analyses. Canada,
Sweden, Poland, and Turkey were considered Europe/North
America; Argentina, Brazil, Colombia, and Chile were considered
South America; United Arab Emirates, Saudi Arabia, Iran, and
Palestine were considered Middle East; South Africa, Tanzania,
and Zimbabwe were considered Africa; Malaysia and Philippines
were considered South East Asia; Pakistan, India, and Bangladesh
were considered South Asia; and Chinawas analysed individually.
Within each region, the median (25th–75th percentile) HGS
was calculated stratiﬁed by age (35–40 years, 41–50 years,
51–60 years, and 61–70 years) and sex. The reference
range is considered the 25th-75th percentile of HGS within
each stratum. The analysis was repeated stratifying by eth-
nicity and by body-mass index. The expected HGS as a
function of age, stratiﬁed by country and sex, was esti-
mated by restricted cubic spline regression with four
knots. We performed sensitivity analyses excluding
participants who reported difﬁculty using their ﬁngers to
grasp or handle.
Results
The proportion of those eligible for the PURE study that
provided consent was 78%. Of 189,990 individuals who
did consent to participate, 31,109 had a history of an
illness that necessitated exclusion from this analysis. A fur-
ther 33,419 participants were not included in this analysis
because HGS was not measured. Therefore the present
study is based on 125,462 individuals. Participant charac-
teristics are displayed in Table 1. Education levels were
highest in Europe/North America and lowest in Africa.
Men had higher employment rates than women, and
employment rates were lowest in Africa. Physical activity
levels were lowest in the Middle East, and were also low
in South East Asia and China. Dietary caloric intake was
lowest in Africa, and the percentage of caloric intake from
protein was lowest in South Asia, followed by Africa. Europeans
were on average tallest, heaviest, and exhibited the largest
waist circumference.
HGS reference ranges by geographic region, age stratum,
and sex are presented in Table 2. HGS among men exceeded
HGS in women, and there was a progressive decline in HGS
with increasing age. Within each age and sex stratum, up to
33% variation in median HGS values was observed among
the different regions. Highest HGS values were found in
Europe/North America, and lowest values in Africa, South
Asia, and Southeast Asia. Average HGS stratiﬁed as a function
of age, stratiﬁed by sex and geographic region is displayed in
Figure 1. Expected HGS together with 95% conﬁdence limits
as a function of age, stratiﬁed by sex and country are
displayed in Figure 2. HGS reference ranges by ethnicity,
age stratum, and sex are presented in the Table 3. The
observed values of HGS in each ethnic group reﬂected the
geographic region where the ethnic group predominates.
Figure 1 Average handgrip strength as a function of age. Nth = North; Sth = South.
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The median, 25th and 75th percentiles for HGS stratiﬁed by sex,
age, geographic region, and body-mass index are presented in
the Appendix Table 6. For this analysis, age was dichotomized
to ≤50years and >50years, and body-mass index was catego-
rized as underweight (body-mass index <18.5 kg/m2), healthy
weight (body-mass index 18.5 to <25kg/m2), overweight
(body-mass index 25 to <30kg/m2), and obese (body-mass
index ≥30kg/m2). This analysis suggests a positive association
between HGS and body-mass index, although the relationship
was less pronounced or even reversed in obese individuals.
Repeating the main analysis after excluding participants
who reported difﬁculty using their ﬁngers to grasp or handle
did not substantially change the medians, 25th and 75th per-
centile values in each stratum (ﬁndings not presented).
Figure 2 Estimated handgrip strength (solid line) as a function of age. The dotted curves represent ±1 standard deviation, and the dashed curves rep-
resent ±2 standard deviations.
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Discussion
This study has reported reference ranges for HGS derived from
healthy community-dwelling adults aged 35-70 years in 21 coun-
tries of all income strata. The key ﬁnding from this analysis is that
median HGS differs among the geographic regions and ethnic
groups studied. Therefore individual HGS measurements should
be interpreted using region/ethnic-speciﬁc reference ranges.
Interpretation of HGS measurement
Numerous studies have reported reference ranges for HGS mea-
surement (Table 4). These studies have each involved popula-
tions from single countries, and have employed different
approaches to measuring and reporting HGS ranges. The large
majority of reports are from high-income countries, and from
populations of predominantly European ethnicity. There is a pau-
city of data from low-income countries, despite the fact that HGS
measurement as an inexpensive risk-stratifying test may be best
suited to these resource-challenged settings.
The values of HGS observed in Europe and North America, and
South America in the present study are similar to those reported
in other studies of individuals from European countries,15 the
US,14 and Brazil22 respectively. This ﬁnding conﬁrms the repro-
ducibility of HGS measurement from an epidemiologic perspec-
tive, and provides face validity to the PURE data. Our study
extends on existing literature to report reference ranges for
HGS from seven geographic regions around the world, many of
which have not previously been studied. We found considerable
heterogeneity in median HGS among healthy adults from these
different regions. This ﬁnding is an important one because we
have previously reported that HGS is predictive of mortality
and CVD independently of country income.5 The present study
will allow the measurement of an individual’s HGS to be placed
into their regional context.
Ethnic variations in muscle strength
Our ﬁndings are consistent with previous work that demon-
strates variations in skeletal muscle mass from individuals of
different ethnicities.27 Taken together, these ﬁndings raise the
hypothesis that genetically mediated ethnic differences in
muscle strength exist. In addition, variations in muscle strength
between people from different countries may be attributed in
part to differences in socio-economic status. In a Spanish study
of 1785 adolescents, a modest association between socio-
economic status and muscle strength was observed.28 A more
profound difference in socio-economic status (in absolute terms)
among participants from countries of contrasting income may
therefore be expected to be associated with a larger differences
in HGS. It is also likely that differences in muscle strength among
diferent countries reﬂects variation in dietary patterns. There is a
well-recognized association between dietary protein intake,
which varies among different countries, and muscle strength.29
Table 4. Representative studies reporting reference ranges for handgrip strength among healthy adults or adults from the general population
Study Population n Age range (years) Dynamometer Hand
Frederiksen et al.15 Danes; general population 8342 45–102 Smedley (TTM; Tokyo, Japan) Maximal
value from both
Tveter et al.16 Norwegians; volunteers
from work places,
schools, community centres
370 18–90 – Average
from both
Vaz et al.23 Indians; university students
and faculty
1024 5–67 Harpenden (CMS Weighing Equipment,
London, UK); Smedley (TTM, Tokyo, Japan)
Non–dominant
Mathiowetz et al.14 Americans; volunteers from
shopping centres, a
rehabilitation centre, a
university
628 20–75 Jamar (Jackson, MI, USA) Both
Ribom et al.17 Swedish men;
general population
999 70–80 Jamar (Jackson, MI, USA) Maximal value
from both
Massy–Westropp et al.18Australian;
general population
2678>20 Jamar Both
Schlüssel et al.22 Brazil; general population 3050>20 Jamar (Sammons–Preston, Korea) Maximal value
from both
Lauretani et al.19 Italy; general population 1030>20 – –
Günther et al.20 Germany; volunteers
from workplaces, retirement
homes
769 20–95 NexGen (Ergonomics Inc, Quebec,
Canada)
Average of
each hand
Snih et al.8 Mexican Americans in
southern states; general
population
2488≥65 years Jamar (J.A.Preston Corp., Clifton,
NJ, USA)
Dominant hand
Kenny et al.21 Irish; general population 5819≥50 years Baseline (Fabrication Enterprises Inc.,
White Plains, NY, USA)
Maximum
value from both
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Remaining uncertainties
While we have speculated about potential reasons for the
differences in HGS among different countries and ethnicities,
the nature of these differences has not been resolved. It is
also uncertain which reference range is best applied to indi-
viduals who migrate from one country to another, or who
are from an ethnic minority within a particular country. These
uncertainties are related to a lack of understanding of what
constitute the most important determinants of muscle
strength, whether ethnic and genetic factors are more impor-
tant than environmental factors, and what duration and ex-
tent of exposure to environmental inﬂuences is needed to
cause change in an individual’s physical characteristics. While
it is likely that differences in dietary quality and physical ac-
tivity levels, as examples of environmental determinants of
HGS, account at least in part for the variation in HGS ob-
served among different regions, we do not present reference
ranges adjusted for these factors because in a given individ-
ual, it is difﬁcult to interpret their observed HGS when com-
pared with the expected HGS of an individual with a
globally average diet and physical activity level.
Limitations
Individuals over the age of 70 years and younger than
35 years were not included, so this study is unable to report
reference ranges for HGS outside this range. Eligible individ-
uals who declined to participate in PURE, or in whom HGS
was not measured, and individuals whose HGS may have
been inﬂuenced by musculoskeletal diseases of the hand,
may have introduced bias or errors.
Conclusion
The expected HGS measurement for an individual of a given
age and sex varies according to their geographic region
and/or ethnicity. HGS measurements should be interpreted
with awareness of such contextual factors. Further research
is needed to evaluate possible determinants of muscle
strenth in order to understand the factors that underlie the
differences in muscle strength among different healthy
populations.
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Table A1. Guidelines for the selection of countries, communities, households and individuals recruited in PURE
Countries
1. HIC, MIC and LIC, with the bulk of the recruitment from low- and middle-income regions.
2. Committed local investigators with experience in recruiting for population studies.
Communities
1. Select both urban and rural communities. Use the national deﬁnition of the country to determine urban and rural communities.
2. Select rural communities that are isolated (distance of >50 km or lack easy access to commuter transportation) from urban centers.
However, consider ability to process bloods samples, eg, villages in rural developing countries should be within 45-min drive of an
appropriate facility.
3. Deﬁne community to a geographical area, eg, using postal codes, catchment area of health service/clinics, census tracts, areas
bordered by speciﬁc streets or natural borders such as a river bank.
4. Consider feasibility for long-term follow-up, eg, for urban communities, choose sites that have a stable population such as residential
colonies related to speciﬁc work sites in developing countries. In rural areas, choose villages that have a stable population. Villages at
greater distance from urban centers are less susceptible to large migration to urban centers.
5. Enlist a community organization to facilitate contact with the community, eg, in urban areas, large employers (government and
private), insurance companies, club, religious organizations, clinic or hospital service regions. In rural areas, local authorities such as
priests or community elders, hospital or clinic, village leader, or local politician.
Individual
1. Broadly representative sampling of adults 35 to 70 years within each community unit.
2. Consider feasibility for long-term follow-up when formulating community sampling framework, eg, small percentage random
samples of large communities may be more difﬁcult to follow-up because they are dispersed by distance. In rural areas of developing
countries that are not connected by telephone, it may be better to sample entire community (ie, door-to-door systematic sampling).
3. The method of approach of households/individuals may differ between sites. In MIC and HIC, followed up by phone contact may be
the practical ﬁrst means of contact. In LIC, direct household contact through household visits may be the most appropriate means of ﬁrst
contact.
4. Once recruited, all individuals are invited to a study clinic to complete standardized questionnaires and have a standardized set of
measurements.
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